KRN 321

Known as: KRN-321, KRN321 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2011
0120012011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Darbepoetin alfa (KRN321) is a recombinant protein that stimulates erythropoiesis by the same mechanism as endogenous… (More)
  • table 2
  • table 3
  • figure 1
  • table 4
  • table 4
Is this relevant?
2008
2008
Darbepoetin alfa (KRN321) is a novel molecule that stimulates erythropoiesis by the same mechanism as endogenous erythropoietin… (More)
Is this relevant?
2007
2007
Darbepoetin alfa (KRN321) is a novel molecule that stimulates erythropoiesis by the same mechanism as endogenous erythropoietin… (More)
Is this relevant?
2007
2007
KRN321 is a hyperglycosylated analogue of recombinant human erythropoietin (rHuEPO, epoetin alfa), and its absorption… (More)
Is this relevant?
2006
2006
KRN321, darbepoetin alfa, is a hyperglycosylated analog of recombinant human erythropoietin (rHuEPO, epoetin alfa). We carried… (More)
Is this relevant?
Review
2001
Review
2001
Amgen has launched darbepoetin alfa, synthetic recombinant novel erythropoiesis stimulating protein (NESP), for the treatment of… (More)
Is this relevant?